Cardiovascular manifestations in idiopathic inflammatory myopathies

[1]  T. Iwaniec,et al.  Thrombin generation potential is increased in patients with autoimmune inflammatory myopathies. , 2022, Advances in medical sciences.

[2]  R. J. van der Geest,et al.  Using multi-parametric quantitative MRI to screen for cardiac involvement in patients with idiopathic inflammatory myopathy , 2022, Scientific Reports.

[3]  H. Mann,et al.  Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study , 2022, Frontiers in Medicine.

[4]  C. Kavadichanda,et al.  COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis , 2022, Seminars in Arthritis and Rheumatism.

[5]  J. Lei,et al.  Thromboembolic events in idiopathic inflammatory myopathy: a retrospective study in China , 2022, Clinical Rheumatology.

[6]  D. Andersson,et al.  Myositis-Specific Autoantibodies and QTc Changes by ECG in Idiopathic Inflammatory Myopathies. , 2022, Rheumatology.

[7]  E. Taraldsrud,et al.  Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis—a cross-sectional study , 2022, Rheumatology International.

[8]  E. Lai,et al.  Premature coronary artery disease in patients with immune-mediated inflammatory disease: a population-based study , 2022, RMD Open.

[9]  Wei Chen,et al.  Relative basal myocardial weakness: differentiating dermatomyositis and polymyositis with cardiac involvement from viral myocarditis using speckle-tracking echocardiography and quantification of myocardial work. , 2021, Quantitative imaging in medicine and surgery.

[10]  L. Qin,et al.  Coronary Heart Disease and Cardiovascular Risk Factors in Patients With Idiopathic Inflammatory Myopathies: A Systemic Review and Meta-Analysis , 2022, Frontiers in Medicine.

[11]  T. Mimori,et al.  ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis , 2022, Frontiers in Immunology.

[12]  L. Qin,et al.  Left ventricle diastolic dysfunction in idiopathic inflammatory myopathies: A meta-analysis and systematic review. , 2021, Modern rheumatology.

[13]  I. Wicks,et al.  Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review. , 2021, Rheumatology.

[14]  Qing-jun Wu,et al.  Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry , 2021, Clinical Rheumatology.

[15]  Hung-An Chen,et al.  Time‐Dependent Analysis of Risk of New‐Onset Heart Failure Among Patients With Polymyositis and Dermatomyositis , 2021, Arthritis & rheumatology.

[16]  M. Needham,et al.  Idiopathic inflammatory myopathies: a review , 2021, Internal medicine journal.

[17]  Geetika Arora,et al.  Arrhythmia prevalence among patients with Polymyositis-Dermatomyositis in the United States: an observational study. , 2021, Heart rhythm.

[18]  A. Mammen,et al.  Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis , 2021, Clinical Rheumatology.

[19]  K. Rossing,et al.  Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy , 2021, Oxford medical case reports.

[20]  M. Holmqvist,et al.  Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies , 2021, Scandinavian journal of rheumatology.

[21]  Jiayu Sun,et al.  Phenotyping of myocardial involvement by cardiac magnetic resonance in idiopathic inflammatory myopathies , 2021, European Radiology.

[22]  J. Lei,et al.  Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody. , 2020, Seminars in arthritis and rheumatism.

[23]  OUP accepted manuscript , 2021, Rheumatology.

[24]  OUP accepted manuscript , 2021, Rheumatology.

[25]  Q. Fang,et al.  Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement. , 2020, Rheumatology.

[26]  F. Ng,et al.  Pro-arrhythmic electrophysiological and structural remodelling in rheumatoid arthritis. , 2020, American journal of physiology. Heart and circulatory physiology.

[27]  M. Beer,et al.  Myocardial involvement and deformation abnormalities in idiopathic inflammatory myopathy assessed by CMR feature tracking , 2020, The International Journal of Cardiovascular Imaging.

[28]  Xiaoyue Zhou,et al.  CMR T1 mapping and strain analysis in idiopathic inflammatory myopathy: evaluation in patients with negative late gadolinium enhancement and preserved ejection fraction , 2020, European Radiology.

[29]  S. Reddy,et al.  High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies. , 2020, Rheumatology.

[30]  M. Milone,et al.  Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. , 2020, Mayo Clinic proceedings.

[31]  D. Benaiges,et al.  Atherosclerosis and inflammation. New therapeutic approaches. , 2020, Medicina clinica.

[32]  F. Ibrahim,et al.  Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis , 2020, Clinical Rheumatology.

[33]  Q. Wang,et al.  Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies. , 2020, Cardiovascular diagnosis and therapy.

[34]  K. Kim,et al.  Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: a nationwide population-based study , 2020, Scandinavian journal of rheumatology.

[35]  Jie Wang,et al.  Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy , 2020, Journal of Cardiovascular Magnetic Resonance.

[36]  E. Roach,et al.  Juvenile Dermatomyositis and the Inflammatory Myopathies , 2020, Seminars in Neurology.

[37]  W. Rottbauer,et al.  Sporadic inclusion body myositis: no specific cardiac involvement in cardiac magnetic resonance tomography , 2020, Journal of Neurology.

[38]  Shuyang Zhang,et al.  Clinical Characteristics, Treatment, and Outcomes in Patients with Idiopathic Inflammatory Myopathy Concomitant with Heart Failure. , 2020, International heart journal.

[39]  Y. Kao Yang,et al.  Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan. , 2019, Rheumatology.

[40]  P. Sanders,et al.  Cardiac involvement in idiopathic inflammatory myopathies detected by cardiac magnetic resonance imaging , 2019, Clinical Rheumatology.

[41]  I. Sjaastad,et al.  Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium to Longstanding Juvenile Dermatomyositis , 2019, Arthritis care & research.

[42]  I. Lundberg,et al.  Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study , 2019, The Journal of Rheumatology.

[43]  I. Lundberg,et al.  Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset , 2018, Arthritis care & research.

[44]  K. Rayner,et al.  Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. , 2018, Atherosclerosis.

[45]  J. Silverberg,et al.  Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample , 2018, Rheumatology.

[46]  J. Sergeant,et al.  Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies , 2018, Rheumatology.

[47]  A. Huber,et al.  Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping , 2018, Journal of Cardiovascular Magnetic Resonance.

[48]  J. Albayda,et al.  Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement. , 2018, Seminars in arthritis and rheumatism.

[49]  J. Lamb,et al.  The EuroMyositis registry: an international collaborative tool to facilitate myositis research , 2017, Annals of the rheumatic diseases.

[50]  G. C. Dobloug,et al.  Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study , 2017, Annals of the rheumatic diseases.

[51]  Hong Tang,et al.  Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study , 2017, The International Journal of Cardiovascular Imaging.

[52]  Y. Lee,et al.  Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis , 2017, Rheumatology International.

[53]  A. Capucci,et al.  Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study , 2017, The Journal of Rheumatology.

[54]  I. Sjaastad,et al.  Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies , 2016, RMD Open.

[55]  S. Kay,et al.  Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities , 2016, Arthritis care & research.

[56]  H. Abenhaim,et al.  Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[57]  R. Miossi,et al.  Electrocardiographic changes in dermatomyositis and polymyositis. , 2016, Revista brasileira de reumatologia.

[58]  A. Gabrielli,et al.  Cardiac involvement in polymyositis and dermatomyositis. , 2016, Autoimmunity reviews.

[59]  I. Sjaastad,et al.  In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset. , 2015, Rheumatology.

[60]  Hyon K. Choi,et al.  Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. , 2015, Rheumatology.

[61]  Hyon K. Choi,et al.  Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study , 2014, Annals of the rheumatic diseases.

[62]  S. Kay,et al.  Traditional Cardiovascular Risk Factors and Coronary Artery Calcification in Adults With Polymyositis and Dermatomyositis: A Danish Multicenter Study , 2015, Arthritis care & research.

[63]  C. Kao,et al.  Increased subsequent risk of acute coronary syndrome for patients with dermatomyositis/polymyositis: a nationwide population-based retrospective cohort study , 2015, Scandinavian journal of rheumatology.

[64]  W. Rottbauer,et al.  Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography , 2015, Journal of Neurology.

[65]  J. Pope,et al.  A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases , 2014, Arthritis Research & Therapy.

[66]  F. Sung,et al.  Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. , 2014, Thrombosis research.

[67]  P. Suksaranjit,et al.  Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. , 2014, Seminars in arthritis and rheumatism.

[68]  A. Sanguankeo,et al.  Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis , 2014, Rheumatology International.

[69]  Hanxion Liu,et al.  Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease , 2014, The Journal of Rheumatology.

[70]  Han Wang,et al.  Altered Lipid Levels in Untreated Patients with Early Polymyositis , 2014, PloS one.

[71]  I. Sjaastad,et al.  In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity , 2013, Annals of the rheumatic diseases.

[72]  P. Stein,et al.  Heart rate variability in risk stratification of cardiac patients. , 2013, Progress in cardiovascular diseases.

[73]  S. Shinjo,et al.  Analysis of Metabolic Syndrome in Adult Dermatomyositis With a Focus on Cardiovascular Disease , 2013, Arthritis care & research.

[74]  Hsiu-Hsi Chen,et al.  Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population‐based longitudinal follow‐up study , 2013, The British journal of dermatology.

[75]  E. Linos,et al.  Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey , 2013, Arthritis Research & Therapy.

[76]  M. Neovius,et al.  Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. , 2012, JAMA.

[77]  F. Maldonado,et al.  Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study , 2012, Respirology.

[78]  I. Marie.  Morbidity and Mortality in Adult Polymyositis and Dermatomyositis , 2012, Current Rheumatology Reports.

[79]  R. Woodman,et al.  Mortality and its predominant causes in a large cohort of patients with biopsy‐determined inflammatory myositis , 2012, Internal medicine journal.

[80]  G. Kitas,et al.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors , 2011, Rheumatology International.

[81]  I. Targoff,et al.  Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. , 2011, International journal of cardiology.

[82]  Sreeram V Ramagopalan,et al.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.

[83]  I. Sjaastad,et al.  Cardiac dysfunction in juvenile dermatomyositis: a case-control study , 2011, Annals of the rheumatic diseases.

[84]  J. Case,et al.  Serum Cardiac Troponin T, But Not Troponin I, Is Elevated in Idiopathic Inflammatory Myopathies , 2009, The Journal of Rheumatology.

[85]  K. Rother,et al.  Metabolic abnormalities and cardiovascular risk factors in children with myositis. , 2009, The Journal of pediatrics.

[86]  Jeroen J. Bax,et al.  The heart in sporadic inclusion body myositis: a study in 51 patients , 2009, Journal of Neurology.

[87]  C. Pineau,et al.  Arterial Events in Persons with Dermatomyositis and Polymyositis , 2009, The Journal of Rheumatology.

[88]  I. Lundberg.  The heart in dermatomyositis and polymyositis. , 2006, Rheumatology.

[89]  G. Borgulya,et al.  Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features: A Longitudinal Study of 162 Cases , 2004, Medicine.

[90]  G. Hughes,et al.  Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.

[91]  F. Apple,et al.  Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.

[92]  G. Hutchins,et al.  The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. , 1982, The American journal of cardiology.